Author:
Vreman Rick A.,de Ruijter Angela S.,Zawada Anna,Tafuri Giovanni,Stoyanova-Beninska Violeta,O’Connor Daniel,Naumann-Winter Frauke,Wolter Franziska,Mantel-Teeuwisse Aukje K.,Leufkens Hubert G.M.,Sidiropoulos Iordanis,Larsson Kristina,Goettsch Wim G.
Subject
Drug Discovery,Pharmacology
Reference67 articles.
1. Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on Orphan Medicinal Products;Anon;Off. J. Eur. Union,1999
2. Inventory of Union and Member State incentives to support research into, and the development and availability of orphan medicinal products. State of Play 2015, European Commission;Anon,2016
3. Post-orphan Medicinal Product Designation Procedures. Guidance for Sponsors, EMA;EMA,2019
4. Demonstrating significant benefit of orphan medicines: analysis of 15 years of experience in Europe;Fregonese;Drug Discov. Today,2018
5. European regulation on orphan medicinal products: 10 years of experience and future perspectives;Committee for Orphan Medicinal Products and the European Medicines;Nat. Rev. Drug Discov.,2011
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献